ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "endothelial cells"

  • Abstract Number: 1980 • 2014 ACR/ARHP Annual Meeting

    Thrombospondin-1 Is Elevetad in the Plasma of Patients with Antiphospholipid Syndrome and Is Correlated with Soluble Fas Ligand and Free Active TGF-B levels

    Markos Patsouras1, Marina Sikara2, Athanasios G. Tzioufas2 and Panayiotis Vlachoyiannopoulos2, 1PATHOPHYSIOLOGY DEPARTMENT, UNIVERSITY OF ATHENS, School of Medicine, National University of Athens, Athens, Greece, 2Pathophysiology, School of Medicine, National University of Athens, Athens, Greece

    Background/Purpose Antiphospholipid syndrome (APS) is an acquired thombophillia characterized by recurrent thromboembolism and pregnancy morbidity. Thrombospondin (TSP-1) is a matricellular glycoprotein with antiangiogenic and proapoptotic…
  • Abstract Number: 1717 • 2014 ACR/ARHP Annual Meeting

    Endothelial to Mesenchymal Transition Contributes to the Development of Pulmonary Vasculopathy in Systemic Sclerosis PAH

    Robert Good1, Adrian Gilbane2, Sarah Trinder2, David Abraham3, Christopher Denton3 and Alan M. Holmes4, 1Rheumatology and Connective Tissue Diseases, UCL, LONDON, United Kingdom, 2Rheumatology and Connective Tissue Diseases, UCL, London, United Kingdom, 3Rheumatology and Connective Tissue Diseases, UCL Medical School, London, United Kingdom, 4Centre for Rheumatology and Connective Tissue Diseases, UCL, London, United Kingdom

    Background/Purpose Vascular complications in Scleroderma (SSc) patients are associated with high mortality, particularly in patients who develop pulmonary arterial hypertension (SSc-PAH). Vascular complications, thought to…
  • Abstract Number: 1704 • 2014 ACR/ARHP Annual Meeting

    CXCL4 Promotes Fibrosis By Increasing Expression of Extracellular Matrix Modifying Factors and By Facilitating Epithelial/Endothelial Mesenchymal Transition

    W. Marut1, A.J. Affandi1, A. Limpers1 and T.R.D.J. Radstake2, 1Immunology, University Medical Center Utrecht, Utrecht, Netherlands, 2Department of Rheumatology & Clinical Immunology, University Medical Center Utrecht, Utrecht, Netherlands

    Background/Purpose Systemic sclerosis (SSc) is a degenerative disorder, characterized by vascular abnormalities and immunological disturbances followed by excessive fibrosis in multiple organ systems. In a…
  • Abstract Number: 1720 • 2014 ACR/ARHP Annual Meeting

    GATA6 Deficiency Activates UPR Pathways in Endothelial Cells during the Development of Pulmonary Arterial Hypertension

    Rong Han1, Rosanne Van Deuren2, Stefania Lenna1, Izabela Chrobak1, Timothy Radstake3, Carol Feghali-Bostwick4 and Maria Trojanowska1, 1Arthritis Center, Boston University, Boston, MA, 2Rheumatology Department, University Medical Center Nijmegen, Nijmegen, Netherlands, 3University Medical Center Utrecht, Utrecht, Netherlands, 4Medical University of South Carolina, Charleston, SC

    Background/Purpose: Pulmonary arterial hypertension (PAH) is a severe lung complication of systemic sclerosis (SSc), and accounts for a large proportion of SSc-related deaths. As a…
  • Abstract Number: 780 • 2014 ACR/ARHP Annual Meeting

    Novel Roles for Zyxin in the Pathogenesis of Giant Cell Arteritis

    Rie Karasawa1, Paul A. Monach2, Mayumi Tamaki1, Takahiro Okazaki3, Masamichi Oh-Ishi4, Yoshio Kodera4, Toshiko Sato1, Shoichi Ozaki5, Kaiyu Jiang6, Kazuo Yudoh1, James N. Jarvis7 and Peter A. Merkel8, 1Institute of Medical Science, St. Marianna University School of Medicine, Kawasaki, Japan, 2Section of Rheumatology, Vasculitis Center, Boston University School of Medicine, Boston, MA, 3Internal Medicine, St. Marianna University School of Medicine, Kawasaki, Japan, 4School of Science, Kitasato University, Sagamihara, Japan, 5Department of Internal Medicine, St. Marianna University School of Medicine, Kawasaki, Japan, 6415 Carmen Road, Apt. 1, The University at Buffalo, Buffalo, NY, 7Pediatrics, The University at Buffalo, Buffalo, NY, 8Vasculitis Center, Division of Rheumatology, University of Pennsylvania, Philadelphia, PA

    Background/Purpose �:The mechanisms of the blood vessel injury in giant cell arteritis (GCA), a systemic vasculitis characterized by inflammation of large- and medium-sized vessels, remain…
  • Abstract Number: 774 • 2014 ACR/ARHP Annual Meeting

    Endothelin-1 Synergistically Increases TGF-β-Induced Hif1α Expression Under Normoxic Conditions during Endothelial-to-Mesenchymal Transition in Murine Endothelial Cells. a Novel Mechanism for the Fibrogenic Effects of Endothelin

    Peter J. Wermuth and Sergio A. Jimenez, Jefferson Institute of Molecular Medicine, Division of Connective Tissue Diseases and Scleroderma Center,Thomas Jefferson University, Philadelphia, PA

    Background/Purpose: Tissue hypoxia is a consequence of vascular damage and Hif-1α accumulation is a major mechanism of hypoxia response pathways.  HIF-1α induces the transcriptional upregulation…
  • Abstract Number: 771 • 2014 ACR/ARHP Annual Meeting

    Development of a Bifluorescent Lineage Tracker Reporter Mouse Strain to Analyze the Phenotypic Conversion of Endothelial Cells into Myofibroblasts in Vivo. Application to Study the Synergistic Effects of Endothelin-1 on TGF-β1-Induced Endothelial-to-Mesenchymal Transition

    Peter J. Wermuth and Sergio A. Jimenez, Jefferson Institute of Molecular Medicine, Division of Connective Tissue Diseases and Scleroderma Center,Thomas Jefferson University, Philadelphia, PA

    Background/Purpose: Endothelial-to-mesenchymal transition (EndoMT) may be a crucial pathway in generating activated myofibroblasts, cells that play a pivotal role in the development of tissue and…
  • Abstract Number: 764 • 2014 ACR/ARHP Annual Meeting

    ERG and FLI1 in Systemic Sclerosis-Associated Pulmonary Complications

    Rong Han and Maria Trojanowska, Arthritis Center, Boston University, Boston, MA

    Background/Purpose: Pulmonary arterial hypertension (PAH) and pulmonary fibrosis (PF) are the two major lung complications associated with the autoimmune disease systemic sclerosis (SSc), and constitute…
  • Abstract Number: 381 • 2013 ACR/ARHP Annual Meeting

    Coronary Endothelial Dysfunction Directly Measured By N13 Positron Emission Tomography (PET) Is Detected In Established Rheumatoid Arthritis (RA), But Not Early RA

    OM Troum1, OL Pimienta1, B Hidalgo2 and WA Hsueh3, 1Keck School of Medicine, University of Southern California, Los Angeles, CA, 2Biostatistics, University of Alabama, Birmingham, AL, 3Medicine, Weill Cornell Medical College, Houston, TX

    Background/Purpose: Rheumatoid arthritis (RA) is associated with increased risk of cardiovascular (CV) disease. The endothelium is a key regulator of vascular function. Subclinical CV disease and…
  • Abstract Number: 2564 • 2013 ACR/ARHP Annual Meeting

    Functional Activation Of The TRPV1 and TRPV2 Non-Selective Cation Channels Potentiates TGF-β1-Induced Endothelial-To-Mesenchymal Transition In Murine Pulmonary Endothelial Cells Suggest a Potential Role Of Trpv Channels In The Pathogenesis Of Systemic Sclerosis

    Peter J. Wermuth and Sergio A. Jimenez, Jefferson Institute of Molecular Medicine, Division of Connective Tissue Diseases and Scleroderma Center,Thomas Jefferson University, Philadelphia, PA

    Background/Purpose: Transient receptor potential (Trp) cation channel, subfamily V (TRPV) members can impact a diverse range of vascular functions, including vascular tone, vascular permeability, mechanosensing,…
  • Abstract Number: 2565 • 2013 ACR/ARHP Annual Meeting

    Synergistic Effects Of Endothelin-1 On Transforming Growth Factor-β1 (TGF-β1) Induced Endothelial-To-Mesenchymal Transition. A Novel Mechanism For The Fibrogenic Effects Of Endothelin

    Peter J. Wermuth, Zhaodong Li and Sergio A. Jimenez, Jefferson Institute of Molecular Medicine, Division of Connective Tissue Diseases and Scleroderma Center,Thomas Jefferson University, Philadelphia, PA

    Background/Purpose: The process of endothelial-to-mesenchymal transition (EndoMT) may be a crucial pathway in the generation of activated myofibroblasts, cells that play a pivotal role in…
  • Abstract Number: 2560 • 2013 ACR/ARHP Annual Meeting

    Analysis Of Global Gene Expression Of Pulmonary Endothelial Cells From Caveolin-1 Knock-Out Mice

    Sonsoles Piera-Velazquez1, Zhaodong Li1, Sankar Addya2, Peter J. Wermuth1 and Sergio A. Jimenez1, 1Jefferson Institute of Molecular Medicine, Division of Connective Tissue Diseases and Scleroderma Center,Thomas Jefferson University, Philadelphia, PA, 2Department of Cancer Biology, Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA

    Background/Purpose: Caveolin-1 (Cav-1) deficiency has recently been shown to participate in the pathogenesis of tissue fibrosis in Systemic Sclerosis (SSc). Although the mechanisms involved have…
  • Abstract Number: 2527 • 2013 ACR/ARHP Annual Meeting

    Association Of Nail Dystrophy With Capillaroscopic Abnormalities, Anti-Endothelial Cell Antibody, Endothelin-1, Activity and Chronicity In Systemic Lupus Erythematosus

    Violeta Higuera1, Luis M. Amezcua-Guerra2, Felipe Massó3, Mariana Patlan4, Hugo Montoya5, Araceli Paez4 and Luis H. Silveira6, 1Rheumatology, Instituto Nacional de Cardiologia Ignacio Chavez, Mexico city, Mexico, 2Rheumatology, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, Mexico, 3Immunology, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, Mexico, 4Immunology, Instituto Nacional de Cardiologia Ignacio Chavez, Mexico city, Mexico, 5Instituto Nacional de Cardiologia Ignacio Chavez, Mexico city, Mexico, 6Rheumatology, Instituto Nacional Cardiología Ignacio Chávez, Mexico City, Mexico

    Background/Purpose: Systemic lupus erythematosus (SLE) is a chronic autoimmune disease of unknown etiology, characterized by a broad spectrum of clinical manifestations. There is a large…
  • Abstract Number: 1373 • 2013 ACR/ARHP Annual Meeting

    Connective Tissue Growth Factor Promotes Angiogenesis Through Increased Notch-1 Signaling in Rheumatoid Arthritis

    Kazuhisa Nozawa1, Maki Fujishiro2, Ayako Yamaguchi1, Mikiko Kawasaki2, Kazuhisa Iwabuchi2, Mitsuaki Yanagida2, Keigo Ikeda3, Shinji Morimoto4, Yoshinari Takasaki5 and Iwao Sekigawa3, 1Rheumatology, Juntendo University School of Medicine, Tokyo, Japan, 2Institute for Environment and Gender Specific Medicine, Juntendo University Graduate School of Medicine, Chiba, Japan, 3Internal Medicine 2, Juntendo University Urayasu Hospital, Tomioka, Urayasu, Chiba, Japan, 4Juntendo University Urayasu Hospital, Tokyo, Japan, 5Division of Rheumatology, Department of Internal Medicine, Juntendo University, Tokyo, Japan

    Background/Purpose:  Increased angiogenesis has been associated with various inflammatory disease states including rheumatoid arthritis (RA), and it has been considered as one of main factors…
  • Abstract Number: 937 • 2013 ACR/ARHP Annual Meeting

    Inhibitor Of DNA Binding 1 Mediates Angiogenesis In Rheumatoid Arthritis By Recruitment Of Endothelial Progenitor Cells

    Takeo Isozaki1, Alisa E. Koch2, M. Asif Amin1, Ali S. Arbab3, Gautam Edhayan4, Christine M. Ha4, Pei-Suen Tsou4, Sean C. Friday4, David A. Fox4 and Jeffrey H. Ruth4, 1Internal Medicine, University of Michigan Medical School, Ann Arbor, MI, 2University of Michigan Medical School, Ann Arbor, MI, 3Diagnostic Radiology, Henry Ford Hospital and Medical Centers, Detroit, MI, 4Internal Medicine, Division of Rheumatology, University of Michigan Medical Center, Ann Arbor, MI

    Background/Purpose: Endothelial progenitor cells (EPCs) are known to induce vasculoproliferative responses within rheumatoid arthritis (RA) synovial tissue (ST). Inhibitor of DNA-Binding 1 (Id1) is a…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology